285 filings
Page 8 of 15
6-K
k54m84r0sc1we385 zt4
15 Oct 20
Report of Foreign Private Issuer for the Month of October, 2020
1:05pm
6-K
fr1yt40znk2v41zxs5y7
8 Oct 20
IMV Provides Updates On COVID-19 Vaccine Program
1:58pm
6-K
a3okfma8ov8bma r5bn
16 Sep 20
IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum
10:53am
UPLOAD
ydvrovq
10 Sep 20
Letter from SEC
12:00am
40-F/A
7h7pj1h
26 Aug 20
Annual report (Canada) (amended)
2:26pm
6-K
hr62caoe 2apc
26 Aug 20
IMV to Participate at Four Upcoming Investor Conferences
10:52am
CORRESP
es07sd71grx16d
26 Aug 20
Correspondence with SEC
12:00am
UPLOAD
udiwk
24 Aug 20
Letter from SEC
12:00am
6-K
w3v2krr8y ad00zer
12 Aug 20
IMV Inc. Announces Second Quarter 2020 Financial Results
9:38am
6-K
swx nhrnun6h8
12 Aug 20
Management’s Responsibility for Financial Reporting
7:08am
6-K
90rsj przamj
5 Aug 20
IMV Receives Funding From Canadian Governmental Agencies for COVID-19 vaccine Phase 1 Clinical Study
12:15pm
6-K
djmj1l17axip96aj
4 Aug 20
Report of Foreign Private Issuer for the Month of August, 2020
9:42am
6-K
twbv qmd3r
29 Jul 20
IMV to Present at BTIG’s Virtual Biotechnology Conference
9:14am
6-K
d6qms4jeu h0
20 Jul 20
IMV Announces Appointment of Michael P. Bailey to Board of Directors
9:38am
6-K
l648pd38
14 Jul 20
IMV Updates Rapid Progress on COVID-19 Vaccine Program
12:26pm
EFFECT
8aq347
8 Jul 20
Notice of effectiveness
12:16am
S-8 POS
1ax49befvgn1 rq9
7 Jul 20
Registration of securities for employees (post-effective amendment)
7:31am
POS AM
mte5 jre1v
7 Jul 20
Prospectus update (post-effective amendment)
7:30am
6-K
j45otjd
30 Jun 20
IMVmaintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus
5:06pm
SUPPL
nguuc1
30 Jun 20
Supplemental materials (foreign)
4:30pm